Previous close | 12.21 |
Open | 12.14 |
Bid | 12.14 x 100 |
Ask | 12.25 x 100 |
Day's range | 12.00 - 12.26 |
52-week range | 9.93 - 23.75 |
Volume | |
Avg. volume | 428,306 |
Market cap | 702.423M |
Beta (5Y monthly) | 0.94 |
PE ratio (TTM) | 9.98 |
EPS (TTM) | 1.22 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | 0.60 (4.91%) |
Ex-dividend date | 28 May 2024 |
1y target est | 15.00 |
PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at the American Diabetes Association’s 84th Scientific Sessions that point to the potential for adults with type 2 diabetes (T2D) to better manage insulin delivery through a patch pump with a larger, 300-unit (u) insulin reservoir, which could provide longer wear times and fewer disposable patches over tim
Embecta Corp. ( NASDAQ:EMBC ), is not the largest company out there, but it led the NASDAQGS gainers with a relatively...
CIXXF, JXN and EMBC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 15, 2024.